No! This will not be done to unborn babies! Prenatal mRNA-based gene therapy

Appraisal of a paper by Hanna and colleagues on their proposition to utilize the mRNA platforms as a novel prenatal therapy – new preprint published

In a recent letter, recently published by the American Journal of Obstetrics & Gynecology, Hanna et al. found transplacental transmission of the mRNA of the COVID-19 mRNA “vaccines” as well as spike protein expression in the placenta.

This, of course, raises serious questions about what this means to the offspring of “vaccinated” women.  Hanna and colleagues have done a lot of work on this important topic. In their most recent publication, they also offer some mechanistic explanations to support the findings of their small study (2 pregnant women).

When I first read this paper, it seemed as if some of the rationale provided was incorrect and instead downplays some of the risks associated with these platforms. Initially, I just wanted to write a short note on it.

However, the more I looked into the publication, the more concerning it is. Strangely, Hanna and collaborators turn their findings on their heads. Whilst in the introduction they mention knowledge gaps, it does not seem they are as much worried about the safety of these products. Rather, in their article they seem to be concerned about utilizing their findings as a novel therapeutic application: prenatal mRNA-based gene therapy!

Their proposition is based on several incorrect understandings of how these platforms work as well as a number of unsubstantiated or incorrect claims.

Paradoxically, they ignored known grave adverse effects from pre-clinical tests that really ought to put an end to the idea of using these platforms on unborn babies!

Of course, key findings in the literature are often disguised and explained away by whichever excuses. Much of the letter by Hanna et al. is in this tone as they praise the safety and efficacy of the shots, emphasize their wide acceptance, and highlight the promises of using them on still-developing fetuses!

Again, the overall agenda of the article seems to be to carve out some new market - prenatal mRNA-based gene therapy. This would be done to provide immunity but also to target diseases. Ironically, they write, in passing, that the mRNA injections are, in fact, “gene therapy.” Well, here, this is something that is wanted as it holds the promise of “early disease intervention.” But they do not admit what this really means that these drugs are untested gene therapies.

To me, this is a final red line. It must not be crossed! There is a lot of hype about these technologies, and the letter by Hanna et al. echoes the prevailing flawed narrative of their modus operandi and other erroneous arguments, including how great they have been for adults.

I just published a new preprint where I critically appraised the recent publication by Hanna and colleagues.  Below is the abstract. I hope to raise awareness of this so that those gene therapy experiments will not be extended to unborn babies!

A recent study by Hanna and collaborators assessed the presence of COVID-19 mRNA products in the placenta and umbilical cord blood following maternal “vaccination” during human pregnancy. Their analysis of 2 pregnant women revealed that the mRNA of the genetic injections was detected in both placentas. Spike protein expression was confirmed in the placenta of one of them. Furthermore, the engineered mRNA was detected in the umbilical cord and maternal blood of one mother, where those samples were available for analysis. They also found that the integrity of the injected mRNA varied across samples, but overall, a substantial or even overwhelming majority consisted of non-integrous species. The authors also provide several theoretical reasons they believe explain their experiential observations. Based on their results but shifting their aim, the authors indicate the benefits of their results and suggest that related gene therapies, particularly mRNA-based treatments, may have great promise as prenatal therapy. This article analyses the findings and interpretations of the study and identifies gaps and inconsistencies in their explanations. It also provides a short synopsis and update on known problems with mRNA injections and outlines major pitfalls and unknowns underlying the promised benefits of their intended prenatal gene therapy applications.

Perhaps any of you have an idea where I could send the preprint. It would need to be a journal that is open-minded and one that has a way to support authors like me (i.e., publication fee) who have no organization behind them and who do all their work at their own expense.

In my preprint, I also gave a short synopsis of the main problems of these platforms (see Figure), trying to incorporate as many new results as possible (a total of 65 references). Doing that was time-consuming but made me once again hopeful that the truth is coming to light. The list of publications is far from complete. Yet, it is encouraging how many there are already that strongly criticize the mRNA platforms! Now, unto stopping the agenda to use them under the guise of treating unborn babies!

Source: Mueller, Siguna. 2024. “Transplacental Transmission of mRNA Injections Confirmed: Does This Evidence by Hanna and Colleagues Support Their Proposition as a Promising Prenatal Gene Therapy?” OSF Preprints. August 25. https://doi.org/10.31219/osf.io/bkzs6

Thanks for reading and sharing!